KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ACM Research (ACMR) EBITDA (2016 - 2025)

Historic EBITDA for ACM Research (ACMR) over the last 10 years, with Q3 2025 value amounting to $58.7 million.

  • ACM Research's EBITDA rose 524.92% to $58.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $139.1 million, marking a year-over-year increase of 146.3%. This contributed to the annual value of $116.0 million for FY2024, which is 3448.02% up from last year.
  • As of Q3 2025, ACM Research's EBITDA stood at $58.7 million, which was up 524.92% from $40.2 million recorded in Q2 2025.
  • ACM Research's 5-year EBITDA high stood at $58.7 million for Q3 2025, and its period low was -$23.6 million during Q2 2022.
  • Its 5-year average for EBITDA is $19.2 million, with a median of $18.4 million in 2023.
  • Its EBITDA has fluctuated over the past 5 years, first plummeted by 32860.46% in 2022, then soared by 145606.71% in 2024.
  • Over the past 5 years, ACM Research's EBITDA (Quarter) stood at $22.1 million in 2021, then soared by 52.2% to $33.6 million in 2022, then grew by 2.83% to $34.5 million in 2023, then plummeted by 61.09% to $13.4 million in 2024, then surged by 336.99% to $58.7 million in 2025.
  • Its last three reported values are $58.7 million in Q3 2025, $40.2 million for Q2 2025, and $26.8 million during Q1 2025.